# A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer

> **NCT02707315** · EARLY_PHASE1 · UNKNOWN · sponsor: **The Cooper Health System** · enrollment: 15 (estimated)

## Conditions studied

- Pancreas Cancer
- Pancreatic Cancer
- Adenocarcinoma of the Pancreas
- Pancreas Adenocarcinoma
- Pancreatic Adenocarcinoma

## Interventions

- **DRUG:** Gemcitabine
- **RADIATION:** Stereotactic Radiosurgery

## Key facts

- **NCT ID:** NCT02707315
- **Lead sponsor:** The Cooper Health System
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-01
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2016-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02707315

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02707315, "A Study of Pre-Operative Cyberknife in Patients With Potentially Resectable Pancreas Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02707315. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*